Transense Technologies plc (TRT.L)
GBp 180.0
(0.0%)
GBp 180.0
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.56 Million | 652 Thousand | 408 Thousand | -257 Thousand | -1.85 Million | -427 Thousand |
| Net Income | 1.56 Million | 1.39 Million | 877 Thousand | 156 Thousand | -2.54 Million | -1.46 Million |
| Depreciation & Amortization | 297 Thousand | 210 Thousand | 243 Thousand | 206 Thousand | 1.04 Million | 481 Thousand |
| Deferred income taxes | -300 Thousand | -530 Thousand | -538 Thousand | -1.18 Million | - | - |
| Stock-based compensation | 130 Thousand | 108 Thousand | 98 Thousand | 41 Thousand | - | - |
| Change in working capital | -103 Thousand | -528 Thousand | -284 Thousand | -728 Thousand | -282 Thousand | 28 Thousand |
| Other non-cash items | -26 Thousand | -4000.00 | 12 Thousand | 1.24 Million | -76 Thousand | 529 Thousand |
| Investing Cash Flow | -883 Thousand | -257 Thousand | -100 Thousand | 1.18 Million | -497 Thousand | -855 Thousand |
| Investments in PPE | -883 Thousand | -257 Thousand | -100 Thousand | -53 Thousand | -1.27 Million | -424 Thousand |
| Acquisitions | - | - | - | 1.23 Million | 772 Thousand | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -455 Thousand | -172 Thousand | 1.23 Million | 1.23 Million | 8000.00 | -431 Thousand |
| Financing Cash Flow | -377 Thousand | -472 Thousand | -299 Thousand | -1.07 Million | 901 Thousand | 2.33 Million |
| Debt repayment | - | -71 Thousand | -976 Thousand | -976 Thousand | -609 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -319 Thousand | -405 Thousand | -303 Thousand | - | - | - |
| Common Stock Issuance | - | 78 Thousand | 78 Thousand | - | - | 2.33 Million |
| Other Financing Activities | 26 Thousand | -74 Thousand | 902 Thousand | -98 Thousand | 1.51 Million | 2.33 Million |
| Accounts receivables | -132 Thousand | -130 Thousand | -569 Thousand | -124 Thousand | -177 Thousand | -91 Thousand |
| Accounts payables | 159 Thousand | -226 Thousand | 300 Thousand | -594 Thousand | 477 Thousand | 247 Thousand |
| Inventory | -130 Thousand | -172 Thousand | -15 Thousand | -10 Thousand | -582 Thousand | 119 Thousand |
| Other working capital | 159 Thousand | - | - | - | - | -247 Thousand |
| Cash at beginning of period | 978 Thousand | 1.05 Million | 1.04 Million | 1.19 Million | 2.64 Million | 1.59 Million |
| Cash at end of period | 1.28 Million | 978 Thousand | 1.05 Million | 1.04 Million | 1.19 Million | 2.64 Million |
| Capital Expenditure | -883 Thousand | -257 Thousand | -100 Thousand | -53 Thousand | -1.27 Million | -424 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | 2000.00 |
| Net cash flow / Change in cash | 303 Thousand | -77 Thousand | 9000.00 | -147 Thousand | -1.45 Million | 1.05 Million |
| Free Cash Flow | 680 Thousand | 395 Thousand | 308 Thousand | -310 Thousand | -3.13 Million | -851 Thousand |
| Breakdown | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 | 2022 Q2 | 2021 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 895 Thousand | 670 Thousand | 1.39 Million | 997 Thousand | 399 Thousand | 877 Thousand |
| Depreciation & Amortization | 181 Thousand | 116 Thousand | 210 Thousand | 105 Thousand | 105 Thousand | 243 Thousand |
| Deferred income taxes | -300 Thousand | -400 Thousand | -530 Thousand | -530 Thousand | -860 Thousand | -538 Thousand |
| Stock-based compensation | - | 54 Thousand | 108 Thousand | 49 Thousand | 59 Thousand | 98 Thousand |
| Change in working capital | 11 Thousand | -44 Thousand | -528 Thousand | 63 Thousand | -591 Thousand | -284 Thousand |
| Other non-cash items | 113 Thousand | -119 Thousand | -4000.00 | 340 Thousand | 716 Thousand | 12 Thousand |
| Investing Cash Flow | -627 Thousand | -256 Thousand | -257 Thousand | -186 Thousand | -71 Thousand | -100 Thousand |
| Investments in PPE | -345 Thousand | -83 Thousand | -257 Thousand | -186 Thousand | -71 Thousand | -100 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -173 Thousand | -172 Thousand | -140 Thousand | -32 Thousand | 1.23 Million |
| Financing Cash Flow | -300 Thousand | -92 Thousand | -472 Thousand | -289 Thousand | -187 Thousand | -299 Thousand |
| Debt repayment | - | -36 Thousand | -71 Thousand | - | -37 Thousand | -976 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -252 Thousand | -67 Thousand | -405 Thousand | -253 Thousand | -152 Thousand | -303 Thousand |
| Common Stock Issuance | - | - | 78 Thousand | - | - | 78 Thousand |
| Other Financing Activities | -48 Thousand | 11 Thousand | -74 Thousand | -2000.00 | 2000.00 | 902 Thousand |
| Accounts receivables | -90 Thousand | -42 Thousand | -130 Thousand | 37 Thousand | -167 Thousand | -569 Thousand |
| Accounts payables | 229 Thousand | -70 Thousand | -226 Thousand | -29 Thousand | -197 Thousand | 300 Thousand |
| Inventory | -128 Thousand | -2000.00 | -172 Thousand | 55 Thousand | -227 Thousand | -15 Thousand |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 1.3 Million | 978 Thousand | 1.05 Million | 625 Thousand | 1.05 Million | 1.04 Million |
| Cash at end of period | 1.28 Million | 1.3 Million | 978 Thousand | 978 Thousand | 625 Thousand | 1.05 Million |
| Capital Expenditure | -345 Thousand | -83 Thousand | -257 Thousand | -186 Thousand | -71 Thousand | -100 Thousand |
| Effect of forex changes on cash | - | 978 Thousand | - | -978 Thousand | 1.05 Million | - |
| Net cash flow / Change in cash | -27 Thousand | 330 Thousand | -77 Thousand | 353 Thousand | -430 Thousand | 9000.00 |
| Free Cash Flow | 555 Thousand | 594 Thousand | 395 Thousand | 642 Thousand | -243 Thousand | 308 Thousand |
TRI
BKT
BIO
VIPS
VLY
8021